HomeAboutCurrent StudiesPrevious StudiesSponsors and CRO'sCareers
ContactMap / Directions
Now offering:  Phase I & Pharmacokinetic Unit

Synopsis of Completed and Current Studies

Asthma and COPD

2004 – PI – William Park, MD (Phase II)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Six Week Study of Efficacy and Safety of an investigational medication for Inhalation in Adults with Chronic Obstructive Pulmonary Disease
 
2004 – PI – William Park, MD (Phase II)
A Four-Week, Double-Blind, Placebo-Controlled Exploratory Evaluation of FEV Changes and Safety of an investigational medication in Patients with Chronic Obstructive Pulmonary Disease (COPD).
 
2003 – William Park, MD (Phase II)
A Double-Blind, Randomized, Multicenter, Two-Part, Parallel-Group, Dose-Ranging Study of Twice-Daily and Once-Daily investigational medication in the Treatment of Subjects with Chronic Obstructive Pulmonary Disease (COPD)
 
1997 PI – Mary Horan, MD
A Multicenter, Double-Blind, Placebo Controlled, Parallel Group Study to Evaluate the Safety , Tolerability and Efficacy of an Investigational Medication for Four Weeks in Out-Patients with Chronic Obstructive Pulmonary Disease
 
1995-1996 PI - Steven McClean, MD
A Comparison Study of Adding an Investigational Medication Versus Doubling the Dose of Beclovent in Asthmatic Subjects Symptomatic on Existing Inhaled Corticosteriods.

RAINIER CLINICAL RESEARCH CENTER

Volunteer for a clinical trial. Your participation in these research studies could help bring new and innovative health care products to market for use by the general population and help contribute to healthier, more productive lives for you and generations to come.
 
Volunteer

Follow us on Twitter
Volunteer Today
For A Better Tomorrow.
 
723 SW 10TH ST, Suite 100
Renton, WA 98057
 
rcrc@rainier-research.com
 
Office: 425-251-1720
Toll Free: 888-478-8343
Fax: 425-251-1723
 
Phase I & Pharmacokinetic UnitPhase I & Pharmacokinetic Unit

CURRENT CLINICAL STUDIES

RAINIER CLINICAL RESEARCH CENTER is currently enrolling studies in a number of areas. Sign up to get involved.